Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Targeting of the CD161 inhibitory receptor enhances T-cell–mediated immunity against hematological malignancies

Francesca Alvarez Calderon, Byong H. Kang, Oleksandr Kyrysyuk, Shiwei Zheng, Hao Wang, Nathan D. Mathewson, Adrienne M. Luoma, Xiaohan Ning, Jason Pyrdol, Xuan Cao, Mario L. Suvà, Guo-Cheng Yuan, K. Dane Wittrup, Kai W. Wucherpfennig

Blood (2024) 143 (12): 1124–1138.

https://doi.org/10.1182/blood.2023022882

Published: 2024

Includes: Supplemental data

Journal Articles

4-1bb Enrichment Enhances Adoptive T Cell Therapy for Hematological Malignancies Using a Novel Approach for Ex Vivo Immune Cell Priming with DC/Tumor Fusion Vaccine

Kathrine S Rallis, Jessica Liegel, Giulia Cheloni, Poorva Bindal, Isabella Saldarriaga, Junyan Zhang, Georges Chedid, Joseph Abirached, John G. Clohessy, Sophia Adamia, Kai W Wucherpfennig, Donald Kufe, Jacalyn Rosenblatt, David Avigan

Blood (2023) 142 (Supplement 1): 2066.

https://doi.org/10.1182/blood-2023-182381

Published: 2023

Journal Articles

Inhibition of MICA and MICB Shedding Enhances Cytokine-Induced Memory-like NK Cell-Mediated Activity Against Multiple Myeloma

Blood (2022) 140 (Supplement 1): 4204–4206.

https://doi.org/10.1182/blood-2022-164811

Published: 2022

Journal Articles

MICA/B antibody induces macrophage-mediated immunity against acute myeloid leukemia

Pedro Henrique Alves da Silva, Samantha Xing, Andriana G. Kotini, Eirini P. Papapetrou, Xiaoyu Song, Kai W. Wucherpfennig, John Mascarenhas, Lucas Ferrari de Andrade

Blood (2022) 139 (2): 205–216.

https://doi.org/10.1182/blood.2021011619

Published: 2022

Includes: Supplemental data

Journal Articles

Dual Chimeric Antigen Receptor Approach Combining Novel Tumor Targeting Strategies Circumvents Antigen Escape in Multiple Myeloma

John Reiser, Ketan Mathavan, Sajid Mahmood, Yijia Pan, Bryan Hancock, Robert Blum, Wen-I Yeh, Andrew Houk, Chia-Wei Chang, Tom Lee, Uta Hopken, John Goulding, Armin Rehm, Kai W. Wucherpfennig, Jode P Goodridge, Ryan Bjordahl, Bahram Valamehr

Blood (2021) 138 (Supplement 1): 1718.

https://doi.org/10.1182/blood-2021-154025

Published: 2021

Journal Articles

Mechanical Checkpoint Regulates Monocyte Differentiation in Fibrotic Matrix

Kyle H Vining, Anna E. Marneth, Kwasi Adu-Berchie, Christina M. Tringides, Joshua M Grolman, Yutong Liu, Waihay J. Wong, Olga Pozdnyakova, Mariano Severgnini, Alexander Stafford, Georg N. Duda, Ann Mullally, Kai W. Wucherpfennig, David J Mooney

Blood (2021) 138 (Supplement 1): 2539.

https://doi.org/10.1182/blood-2021-147297

Published: 2021

Journal Articles

Development of a Novel MICA/B-Specific CAR As a Pan-Tumor Targeting Strategy for Off-the-Shelf, Cell-Based Cancer Immunotherapy

Ryan Bjordahl, PhD, John Goulding, PhD, Mochtar Pribadi, PhD, Robert Blum, MS, Chiawei Chang, Yijia Pan, PhD, Lucas Ferrari de Andrade, PhD, Kai W. Wucherpfennig, Yu-Waye Chu, MD, Hui-yi Chu, PhD, Wen-I Yeh, PhD, Svetlana Gaidarova, MS, Ellen Liu, PhD, Shohreh Sikaroodi, PhD, Lauren Fong, PhD, Janel Huffman, MS, Tom Lee, PhD, Bahram Valamehr, PhD

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-141095

Published: 2020

Journal Articles

Immune-Tumor Interactions in Resistance to Cancer Immunotherapy

Kai W. Wucherpfennig, MD PhD

Blood (2019) 134 (Supplement_1): SCI-45.

https://doi.org/10.1182/blood-2019-121065

Published: 2019

Journal Articles

The shared tumor-associated antigen cytochrome P450 1B1 is recognized by specific cytotoxic T cells

Britta Maecker, David H. Sherr, Robert H. Vonderheide, Michael S. von Bergwelt-Baildon, Naoto Hirano, Karen S. Anderson, Zhinan Xia, Marcus O. Butler, Kai W. Wucherpfennig, Carl O'Hara, Geoffrey Cole, Silvia S. Kwak, Urban Ramstedt, Andy J. Tomlinson, Roman M. Chicz, Lee M. Nadler, Joachim L. Schultze

Blood (2003) 102 (9): 3287–3294.

https://doi.org/10.1182/blood-2003-05-1374

Published: 2003

Journal Articles

Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application

Michael S. von Bergwelt-Baildon, Robert H. Vonderheide, Britta Maecker, Naoto Hirano, Karen S. Anderson, Marcus O. Butler, Zhinan Xia, Wan Y. Zeng, Kai W. Wucherpfennig, Lee M. Nadler, Joachim L. Schultze

Blood (2002) 99 (9): 3319–3325.

https://doi.org/10.1182/blood.V99.9.3319

Published: 2002

NARROW

Targeting of the CD161 inhibitory receptor enhances T-cell–mediated immunity against hematological malignancies

4-1bb Enrichment Enhances Adoptive T Cell Therapy for Hematological Malignancies Using a Novel Approach for Ex Vivo Immune Cell Priming with DC/Tumor Fusion Vaccine

Inhibition of MICA and MICB Shedding Enhances Cytokine-Induced Memory-like NK Cell-Mediated Activity Against Multiple Myeloma

MICA/B antibody induces macrophage-mediated immunity against acute myeloid leukemia

Dual Chimeric Antigen Receptor Approach Combining Novel Tumor Targeting Strategies Circumvents Antigen Escape in Multiple Myeloma

Mechanical Checkpoint Regulates Monocyte Differentiation in Fibrotic Matrix

Development of a Novel MICA/B-Specific CAR As a Pan-Tumor Targeting Strategy for Off-the-Shelf, Cell-Based Cancer Immunotherapy

Immune-Tumor Interactions in Resistance to Cancer Immunotherapy

The shared tumor-associated antigen cytochrome P450 1B1 is recognized by specific cytotoxic T cells

Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only